Investors usually flock to defensive stock names during a bear market or when they are concerned that the market may not run much more. Whether this is becoming a bear market or…
There is always one interesting notion when there is a day that the market has fallen out of bed. There are almost always some stocks which rally because of news or developments,…
Earnings season has taken out some of the sting from biotech and biohealth trading reactions. Today’s version of the BioHealth Business Daily is showing news and moves seen in Charles River Laboratories…
Monday is seeing many winners and losers in the healthcare sector on the heels of the health care reform passage in the House of Representatives this weekend. We are focusing solely on…
This week is a jam-packed list full of the Unusual Suspects. We have many earnings reports, enough that we had to screen out some, and we have many issues to watch for…
Reuters: China will send an envoy to the US to discuss the yuan. Reuters: European carriers who lost money on the Apple (AAPL) iPhone won’t do the same in their deals to…
These are some of the top movers in the world of BioHealth investing. It is usual that drug companies and biotech stocks have major volatility around news and these are examples of…
Douglas A. McIntyre Twitter has, by most estimates, 75 million visitors a month, which makes it one of the largest social networds in the world. All major media companies have a presence on Twitter and…
These are this Tuesday’s top 10 analyst upgrades, downgrades, and initiations seen in Wall Street research calls during the pre-market hours. It is more skewed to downgrades, something we have not seen…
Reuters: Toyota (TM) said it found no electronic safety problems with its cars. Reuters: China said it was committed to US debt but worried about gold. Reuters: Japanese car companies are studying…
Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line data, a new biotech-based treatment, and a massive potential market. With help…
These are ten of the top analyst upgrades and downgrades that are independent of earnings news from Wall Street this Thursday morning: ABB (ABB) Cut to Hold at Societe Generale. Air Products…
These are the top pre-market analyst upgrades and positive research calls from Wall Street we have seen this Wednesday morning with more than two hours until the market opens: Allergan (AGN) Started…
According to Reuters, a poll of economists says the Japanese economy is likely to get worse. Reuters reports that Trump Entertainment may file for Chapter 11. Reuters writes that California may have…
It is getting rather thin in analyst coverage, but these are the top ten analyst upgrades and downgrades we have seen this Wednesday morning: ActivIdentity (NASDAQ: ACTI) Started as Buy at Stanford…
